Clinical Trials in Atlanta

Showing 10161-10180 of 19,805 trials

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

NCT00028366

Ritonavir (RTV) is a protease inhibitor (PI) commonly used to increase drug levels of other PIs in HIV drug treatment. The purpose of this study is to compare a combination of drugs which includes RTV and 2 protease inhibitors (PIs) with 2 combinations that include RTV and another PI. This study also will compare the effectiveness, safety, tolerability, and drug levels in the blood of these anti-HIV drug combinations.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)56 participants

Los Angeles, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

NCT00006145

Cytomegalovirus (CMV) infection is a common opportunistic infection (OI) in HIV patients. The purpose of this study is to find out whether valganciclovir, an antiviral approved by the FDA for the treatment of CMV in the eye, is safe and effective in preventing CMV organ damage in people with HIV.

Cytomegalovirus InfectionsHIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)350 participantsStarted Aug 2000

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +54 more locations

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Find Trials by Condition in Atlanta

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

A Study of HIV-Disease Development in Aging

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems

Longitudinal Performance of Epi proColon

Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)

Adding New Drugs for HIV Infected Patients Failing Current Therapy

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults